Looking for the cheapest marijuana stocks to buy in 2019? Check out this guide where we break down what you need to know. Read More
Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.
Troubled Wells Fargo has a long history of paying a healthy dividend, but is the payout under threat by factors now beyond the bank's control? Read More
This global colossus dominates the thriving management consulting industry. But as the pace of change accelerates, can the company stay on top? Read More
An examination of Therapix Biosciences, its rivals, and a prediction for this micro-cap biotech stock in 2019. Will Therapix prove a winner or loser in the race to develop cannabis-based drugs? Read More
Our review of clinical-stage medical cannabis companies continues, with a fledgling biotech that's generating especially keen interest on Wall Street. Is Cara a future bonanza... or short-term fad? Read More
We spotlight Intec Pharma, its rivals, and whether the stock is overpriced or underpriced. Is this Israel-based biotech on the verge of launching blockbuster new drugs? Read More